
|Videos|December 10, 2011
Dr. Feldman Discusses the Difficulties of Rare Lymphomas
Author(s)Tatyana Feldman, MD
Dr. Tatyana Feldman from John Theurer Cancer Center Discusses the Difficulties of Rare Lymphomas
Advertisement
Tatyana Feldman, MD, a hematologist and oncologist who specializes in lymphoma at John Theurer Cancer Center at Hackensack University Medical Center in Hackensack, NJ, discusses how difficult it is to treat rare forms of lymphoma. Many of these cases are diagnosed in early stages and pose more of a nuisance to the patient, but later stages are very serious, and there are not as many good therapies that exist for treating this relatively small population of patients.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on OncLive
1
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
2
Real-World Data Support Clinical Benefit With Lifileucel in Previously Treated Advanced Melanoma
3
FDA Updates Axi-Cel Label to Remove Limitation of Use in R/R PCNSL
4
Dr Riedell on the Long-Term Efficacy of Tisa-Cel in R/R Follicular Lymphoma
5




































